Table 1.
Objectives | Intervention | Comparator |
---|---|---|
To assess the efficacy of taxanes in comparison to anthracyclines as NACT | Taxanes | Anthracyclines |
Taxanes with anthracyclines | ||
To assess the efficacy of targeted therapy along with NACT | Targeted therapy with anthracyclines | Anthracyclines |
Targeted therapy with taxanes | Taxanes | |
Targeted therapy with anthracyclines and taxanes | Anthracyclines and taxanes | |
To assess the efficacy of trastuzumab along with NACT | Trastuzumab with anthracyclines | Anthracyclines |
Trastuzumab with taxanes | Taxanes | |
Trastuzumab with anthracyclines and taxanes | Anthracyclines and taxanes | |
To assess the efficacy of Bevacizumab along with NACT | Bevacizumab with anthracyclines | Anthracyclines |
Bevacizumab with taxanes | Taxanes | |
Bevacizumab with anthracyclines and taxanes | Anthracyclines and taxanes | |
Network Meta-analysis | All possible and feasible pairs of regimen comparison |
NACT- Neoadjuvant Chemotherapy